Energy metabolism patterns in mammalian myocardium adapted to chronic physiopathological conditions

Cardiovascular Research

Volumn 31, Issue 1, 1996, Pages 163-171

  Rossi, André ^a   Lortet, Sylviane ^a   Aussedat, J ^b   Grably, S ^b   Lavanchy, N ^b   Novel, V ^b   Ray, A ^b   Zimmer, H G ^e   Heckmann, M ^e   Sassard, J ^c   Vincent, M ^c   Caldarera, C ^d   Guarnieri, C ^d   Finelli, C ^d  

^a UNIV GRENOBLE ALPES   (France)

^b Lab de Physiol Cell Cardiaque   (France)

^c Lab d'Etud Experimentales l'H   (France)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e NONE

Author keywords

Energy metabolism; Hart; Hypertrophy; Overload; Phosphorylated compounds

Indexed keywords

ARTICLE; ENERGY METABOLISM; HEART HYPERTROPHY; HUMAN; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHOSPHORYLATION; PRIORITY JOURNAL; SPECTROSCOPY;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARDIOMEGALY; CHRONIC DISEASE; ENERGY METABOLISM; MYOCARDIUM; RATS;

EID: 19244380487     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/0008-6363(95)00183-2     Document Type: Article

References (90)

1. Chance B, Williams G. Respiratory enzymes in oxidative phosphorylation. J Biol Chem 1955;217:383-393
2. Nishiki K, Erecinska M, Wilson DF. Energy relationships between cytosolic metabolism and mitochondrial respiration in the isolated perfused rat heart under various work loads. Am J Physiol 1978; 234:C73-C81.
3. Giesen J, Kammermeier H. Relationship of phosphorylation potential and oxygen consumption in isolated perfused rat hearts. J Mol Cell Cardiol 1980;12:891-907.
4. Saks CA, Kupriyanov VV, Elizarova GV, Jacobus WE. Studies of energy transport in heart cells. The importance of creatine kinase localization for the coupling of mitochondrial phosphorylcreatine production to oxidative phosphorylation. J Biol Chem. 1980;255: 755-763
5. Erecinska M, Wilson DF. Regulation of cellular energy metabolism. J. Membrane Biol 1982;70:1-14.
6. Jacobus WE, Moreadith RW, Vandegaer KM. Mitochondrial respiratory control: evidence against the regulation of respiration by extramitochondrial phosphorylation potentials or by ATP/ADP ratios. J Biol Chem 1982;257:2397-2402.
7. Jacobus WE. Respiratory control and the integration of heart high-energy phosphate metabolism by mitochondrial creatine kinase. Annu Rev Physiol 1985;47:705-725.
8. Gibbs C. The cytoplasmic phosphorylation potential. Its possible role in the control of myocardial respiration and cardiac contractility. J Mol Cell Cardiol 1985;17:727-731.
9. Hassinen IE. Mitochondrial respiratory control in the myocardium. Biochim Biophys Acta 1986;853:135-151.
10. Balaban RS. Regulation of oxidative phosphorylation in the mammalian cell. Am J Physiol 1990;258:C377-C389.
11. 2+ as a second messenger within mitochondria of the heart and other tissues. Annu Rev Physiol 1990;52:451-466.
12. Heinemann FW, Balaban RS. Control of mitochondrial respiration in the heart in vivo. Annu Rev Physiol 1990;52:523-542.
13. Walliman T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the phosphocreatine circuit for cellular energy homeostatis. Biochem J 1992;281:21-40.
14. Harris DA, Das AM. Control of mitochondrial ATP synthesis in the heart. Biochem J 1991;280:561-573.
15. Balaban RS, Kantor HL, Katz LA, Briggs RW. Relation between work and phosphate metabolite in the in vivo paced mammalian heart. Science 1986;232:1121-1123.
16. 31P-NMR study of some metabolic and functional effects of the inotropic agents epinephrine and ouabain, and ionophore RO2-2985 (X537A) on the isolated, perfused rat heart. Biochim Biophys Acta 1982;720:163-171.
17. 31P-NMR studies on respiratory regulation on the intact myocardium. FEBS Lett 1986;206:257-261.
18. 31P NMR and NADH fluorescence study. FEBS Lett 1987;221:270-276.
19. 31P-NMR study. Am J Physiol 1988;255:H185-H188.
20. Rabinowitz M, Zak R. Biochemical and cellular changes in cardiac hypertrophy. Annu Rev Med 1972;23:245-262.
21. Zak R. Factors controlling cardiac growth. In: Zak R, ed. Growth of the Heart in Health and Disease. New York: Raven Press, 1984;165-185.
22. Swynghedauw B. Developmental and functional adaptation of contractile proteins in cardiac and skeletal muscle. Physiol Rev 1986;66:710-771.
23. Bugaisky L, Zak R. Biological mechanism of hypertrophy. In: Fozzard HA et al., ed.: The Heart and Cardiovascular System. New York: Raven Press, 1986;1491-1506.
24. Lakatta EG, Yin FCP. Myocardial ageing: functional alterations and related cellular mechanisms. Am J Physiol 1982;242:H927-H941.
25. Lakatta EG. Cardiac muscle changes in senescence. Annu Rev Physiol 1987;49:519-531.
26. Hansford RG. Bioenergetics in ageing. Biochem Biophys Acta 1983;726:41-80.
27. Pool PE, Spann JE, Buccino RA, Sonnenblick EH, Braunwald E. Myocardial high energy phosphate stores in cardiac hypertrophy and heart failure. Circ Res 1967;21:365-372.
28. Meerson FZ. The myocardium in hyperfunction, hypertrophy, and heart failure. Circ Res 1969;25(suppl II):1-163.
29. Meerson FZ, Pomoinitsky VD. The role of high-energy phosphate compounds in the development of cardiac hypertrophy. J. Mol Cell Cardiol 1972;4:571-597.
30. Zimmer HG, Gerlach E. Early metabolic alterations during the development of experimentally induced cardiac hypertrophy. Arzneim-Forsch./Drug Res 1980;30:2001-2007.
31. Lortet S, Zimmer HG, Rossi A Inotropic response of the rat heart during development and regression of triiodothyronine-induced hypertrophy. J Cardiovasc Pharmacol 1989;14:707-712.
32. 31P-NMR study. Am J Physiol 1991;260:H110-H117.
33. 31P nuclear magnetic resonance. Cardioscience 1992;3:233-239.
34. 31P nuclear magnetic resonance study. Moll Cell Biochem 1993;119:43-50.
35. 31P-NMR study on the isolated rat heart. Acta Physiol Scand 1993;149:311-321.
36. 31P NMR study. Cardiovasc Res 1993;27:1978-1982.
37. Alpert NR, Hamrell BB, Halpern W. Mechanical and biochemical correlates of cardiac hypertrophy. Circ Res 1974;34(suppl II):71-82.
38. Jacob R, Kissling G, Rupp H, Vogt M. Functional significance of contractile proteins in cardiac hypertrophy and failure. J Cardiovasc Pharmacol: 1987;10 (suppl 6):S12-S12.
39. Alpert NR, Mulieri LA. Heat, mechanics and myosin ATPase activity in normal and hypertrophied heart muscle. Fed Proc 1982;41:192-198.
40. Maughan D, Low E, Litten R, Brayden J, Alpert N. Calcium activated muscle from hypertrophied rabbit hearts. Mechanical and correlated biochemical changes. Circ Res 1979;44:279-287.
41. Alpert NR, Mulieri LA. Determinants of energy utilization in the activated myocardium. Fed Proc 1986;45:2597-2600.
42. Hoh JFY, Egerton LJ. Action of triiodothyronine on the synthesis of rat ventricular myosin isoenzymes. Febs Lett 1979;101:143-148.
43. Lompre AM, Schwartz K, Albis A, Lacombe G, Thiem NV, Swynghedauw B. Myosin isozymes redistribution in chronic heart overloading. Nature (Lond.) 1979;282:105-107.
44. Mercadier JJ, Lompre AM, Wisnewsky C, Samuel JL, Bercovici J. Swynghedauw B, Schwartz K. Myosin isoenzyme changes in several models of rat cardiac hypertrophy. Circ Res 1981;49:525-532.
45. Swynghedauw B, Moalic JM, Lecarpentier Y, et al. Adaptational changes in contractile proteins in chronic cardiac overloading: structure and rate of synthesis. In: Alpert NR, ed. Myocardial Hypertrophy and Failure. New York: Raven Press, 1983;465-476.
46. Schwartz K, Lecarpentier Y, Martin JL, Lompre AM, Mercadier JJ, Swynghedauw B. Myosin isoenzymic distribution correlates with speed of myocardial contraction. J Mol Cell Cardiol 1981;13:1071-1076.
47. Pagani ED, Julian FJ. Rabbit papillary muscle isoenzymes and the velocity of papillary muscle shortening. Circ Res 1984;54:586-594.
48. Hamrell B, Alpert NR. Cellular basis of mechanical properties of hypertrophied myocardium. In: Fozzard HA et al., eds. The Heart and Cardiovascular system. New York: Raven Press, 1986, 1507-1524.
49. Alpert NR, Mulieri LA Thermomechanical economy of hypertrophied hearts. In: Alpert, NR, ed. Myocardial Hypertrophy and Failure. New York: Raven Press, 1983; 619-630.
50. Litten RZ, Martin BJ, Low RB, Alpert NR. Altered myosin isoenzyme patterns from pressure-overloaded and thyrotoxic hypertrophied rabbit hearts. Circ Res 1982;50:856-864.
51. Schiaffino S, Gorza L, Sartore S. Distribution of myosin types in normal and hypertrophied hearts: an immunocytochemical approach. In: Alpert, NR, ed. Myocardial Hypertrophy and Failure. New York: Raven Press, 1983;149-166.
52. Morano I, Lengsfeld M, Ganten U, Ganten D, Ruegg JC. Chronic hypertension changes myosin isoenzyme pattern and decreases myosin phosphorylation in the rat heart. J Mol Cell Cardiol 1988; 20:875-886.
53. 2+ ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc Natl Acad Sci USA 1989;86:2966-2970.
54. Zak R, Rabinowitz M. Molecular aspects of cardiac hypertrophy. Annu Rev. Physiol 1979;41:539-552.
55. Page E, Polimeni PI, Zak R, Earley J, Johnson M. Myofibrillar mass in rat and rabbit heart muscle: correlation of microchemical and stereological measurements in normal and hypertrophied heart. Circ Res 1972;30:430-439.
56. Zak R, Rabinowitz M, Rajamanickam C, Merten S, Kwiatkowska-Patzer B. Mitochondrial proliferation in cardiac hypertrophy. Basic Res Cardiol 1980;75:171-178.
57. Anversa P, Loud AV, Vitali-Mazza L. Morphometry and autoradiography of early hypertrophic changes in the ventricular myocardium of adult rat: an electronic microscopic study. Lab Invest 1976;35:475-483.
58. Bishop SP, Cole CR. Ultrastructural changes in the canine myocardium with right ventricular hypertrophy and congestive heart failure. Lab Invest 1969;20:219-229.
59. Hatt PY. Cellular changes in mechanically overloaded heart. Basic Res Cardiol 1977; 72:198-202.
60. Rabinowitz M, Zak R. Mitochondria and cardiac hypertrophy. Circ Res 1975;36:367-376.
61. Albin R, Dowell RT, Zak R, Rabinowitz M. Synthesis and degradation of mitochondrial components in hypertrophied rat heart. Biochem J 1973;136:629-637.
62. Fizelova A, Fizel A. Cardiac hypertrophy and heart failure: dynamics of change in proteins and nucleic acids. J Mol Cell Cardiol 1970;1:389-402.
63. Stoner CO, Ressalat MM, Strak HD. Oxidative phosphorylation in mitochondria isolated from chronically stressed dog hearts. Circ Res 1968;23:87-97.
64. Cooper G, Satava RM, Harrison CE, Coleman HN. Mechanisms for abnormal energetics of pressure-induced hypertrophy of the cat myocardium. Circ Res 1973;33:213-223.
65. Sordahl LA, McCollum WB, Wood WG, Schwartz A. Mitochondria and sarcoplasmic reticulum function in cardiac hypertrophy and failure. Am J Physiol 1973;224:497-502.
66. Rouslin W, Cubicciotti RS, Edwards WD, et al. Phosphorylative respiratory activity of mitochondria isolated from left and right ventricles of rabbit hearts following partial pulmonary trunk occlusion. J Mol Cell Cardiol 1979;11:91-99.
67. Manzelmann MS, Harmon HJ. Lack of age dependent changes in rat heart mitochondria. Mech Ageing Dev 1987;39:281-288.
68. Gadaleta MN, Petruzzella V, Renis M, Fracasso F, Cantatore D. Reduced transcription of mitochondrial DNA in the senescent rat. Tissue dependence and effect of acetyl-L-carnitine. Eur J Biochem 1990;187:501-506.
69. Das AM, Harris DA. Defects in regulation of mitochondrial ATP synthase in cardiomyocytes from spontaneously hypertensive rats. Am J Physiol 1990;28:H1264-H1269.
70. Das AM, Harris DA. Control of mitochondrial ATP synthase in rat cardiomyocytes: effects of thyroid hormone. Biochim Biophys Acta 1991;1096:284-290.
71. 1 ATP synthase. Arch Gerontol Geriatr 1992;14:299-308.
72. 0 ATPase from bovine heart mitochondria. Biochemistry 1991;30:5369-5378.
73. Luciakova K, Nelson BD. Transcript levels for nuclear-encoded mammalian mitochondrial respiratory-chain components are regulated by thyroid hormone in an uncoordinated fashion. Eur J Biochem 1992;207:247-251.
74. Muscari C, Frascaro M, Guarnieri C, Caldarera CM. Mitochondrial function and superoxide generation from submitochondrial particles of aged rat hearts. Biochim Biophys Acta 1990;1015:200-204.
75. Bishop SP, Atschuld RR. Evidence for increased glycolytic mechanism in cardiac hypertrophy and congestive heart failure. In: Alpert NN, ed. Cardiac Hypertrophy. New York: Academic Press, 1971;567-585.
76. Valadares JRE, Singhal RL, Parulekar MR, Beznak M. Influence of aortic coarctation on myocardial glucose-6-phosphate dehydrogenase. Can J Physiol Pharmacol 1969;47:388-391.
77. 31P-NMR study. Biochim Biophys Acta 1990;1055:107-116.
78. El Alaoui-Talibi Z, Moravec J. Carnitine transport and exogenous palmitate oxidation in chronically volume-overload rat hearts. Biochim Biophys Acta 1989;1003:109-114.
79. Abu-Erreish GM, Neely JR, Whitmer JT, Whitman V, Sanadi DR. Fatty acid oxidation by isolated perfused working hearts of aged rats. Am J Physiol 1977;232:E258-E262.
80. Saks VV, Rosenshtraukh LV, Smirnov VN, Chazov EI. Role of creatine phosphokinase in cellular function and metabolism. Can J Physiol Pharmacol 1978;56:691-706.
81. Bessman SP, Geiger PJ. Transport of energy in muscle. The phosphorylcreatine shuttle. Science 1981;211:488-492.
82. Jacobus WE, Saks VA. Creatine kinase of heart mitochondria: changes in its kinetic properties induced by coupling to oxidative phosphorylation. Arch Biochem Biophys 1982;219:167-178.
83. Meyer RA, Sweeney HL, Kushmerick MJ. A simple analysis of the "phosphocreatine shuttle". Am J Physiol 1984;246:C365-377.
84. Ingwall JS. The hypertrophied myocardium accumulates the MB-creatine kinase isoenzyme. Eur Heart J 1984;5(suppl F):129-139.
85. Ingwall JS, Kramer MF, Fifer MA, et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 1985;313:1050-1054.
86. Younes A, Schneider JM, Bercovici J, Swynghedauw B. Creatine kinase isoenzymes redistribution in chronically overloaded myocardium. Cardiovasc Res 1985;19:15-19.
87. Smith SH, Kramer MF, Reis I, Bishop SP, Ingwall JS. Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy. Circ Res 1990;67:1334-1344.
88. Veksler VI, Ventura-Clapier R, Lechene P, Vassort G. Functional state of myofibrils, mitochondria and bound creatine kinase in skinned ventricular fibers of cardiomyopathic hamsters. J Mol Cell Cardiol 1988;20:329-342.
89. Savabi F. Mitochondrial creatine phosphokinase deficiency in diabetic rat heart. Biochem Biphys Res Commun 1988;154:469-475.
90. Popovitch BK, Boheler KR, Dillmann WH. Diabete decreases creatine kinase enzyme activity and mRNA level in the rat heart. Am J Physiol 1989;257:E573-E577.